AU606574B2 - Hepatitis b surface antigen formed by recombinant dna techniques, vaccines diagnostics, cell lines and methods of forming same - Google Patents

Hepatitis b surface antigen formed by recombinant dna techniques, vaccines diagnostics, cell lines and methods of forming same

Info

Publication number
AU606574B2
AU606574B2 AU56114/86A AU5611486A AU606574B2 AU 606574 B2 AU606574 B2 AU 606574B2 AU 56114/86 A AU56114/86 A AU 56114/86A AU 5611486 A AU5611486 A AU 5611486A AU 606574 B2 AU606574 B2 AU 606574B2
Authority
AU
Australia
Prior art keywords
vaccines
diagnostics
hepatitis
methods
cell lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU56114/86A
Other versions
AU5611486A (en
Inventor
Mark L. Rohrbaugh
John S. Salstrom
Hans Thoma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endotronics Inc
Original Assignee
Endotronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endotronics Inc filed Critical Endotronics Inc
Publication of AU5611486A publication Critical patent/AU5611486A/en
Application granted granted Critical
Publication of AU606574B2 publication Critical patent/AU606574B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU56114/86A 1985-04-15 1986-04-15 Hepatitis b surface antigen formed by recombinant dna techniques, vaccines diagnostics, cell lines and methods of forming same Ceased AU606574B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP85104521 1985-04-15
EP85104521 1985-04-15
US85056786A 1986-04-11 1986-04-11
US850567 1997-05-02

Publications (2)

Publication Number Publication Date
AU5611486A AU5611486A (en) 1986-10-23
AU606574B2 true AU606574B2 (en) 1991-02-14

Family

ID=26096680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56114/86A Ceased AU606574B2 (en) 1985-04-15 1986-04-15 Hepatitis b surface antigen formed by recombinant dna techniques, vaccines diagnostics, cell lines and methods of forming same

Country Status (9)

Country Link
KR (1) KR960004264B1 (en)
AU (1) AU606574B2 (en)
DK (1) DK171386A (en)
FI (1) FI95045C (en)
HU (1) HUT40699A (en)
NO (1) NO861450L (en)
NZ (1) NZ215820A (en)
OA (1) OA08238A (en)
PT (1) PT82392B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619753B2 (en) * 1987-06-22 1992-02-06 Medeva Holdings B.V. Hepatitis b surface antigen vaccine

Also Published As

Publication number Publication date
PT82392A (en) 1986-05-01
AU5611486A (en) 1986-10-23
DK171386A (en) 1986-10-16
NZ215820A (en) 1989-01-06
HUT40699A (en) 1987-01-28
DK171386D0 (en) 1986-04-15
FI95045C (en) 1995-12-11
KR860008284A (en) 1986-11-14
FI861559A (en) 1986-10-16
KR960004264B1 (en) 1996-03-30
OA08238A (en) 1987-10-30
NO861450L (en) 1986-10-16
FI861559A0 (en) 1986-04-14
FI95045B (en) 1995-08-31
PT82392B (en) 1988-03-03

Similar Documents

Publication Publication Date Title
IL78472A0 (en) Hepatitis b surface antigen formed by recombinant dna techniques,vaccines,diagnostics,cell lines and methods of forming same
AU1093088A (en) Hepatitis b virus surface antigens and hybrid antigens containing them
HU9502949D0 (en) Polipeptides, polinucleotides, vectors and host cells, and vaccines against hepatitis virus infection, diagnostics, immunoassay and culturing methods
KR870007282A (en) Method for producing hepatitis B virus protein from yeast
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
IL69423A0 (en) Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
ZA862812B (en) Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods
AU5941486A (en) Tetanus vaccine from cloned antigen
EP0105149A3 (en) Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen
AU5112990A (en) Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum
EP0232410A4 (en) Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells.
IL72452A0 (en) Method for the preparation of yeast chromatin and its use for obtaining antibodies for the detection of mammalian carcinomas
EP0174444A3 (en) Hepatitis surface antigen particle vaccine
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
EP0252737A3 (en) Improved strains of yeast for the expression of heterologous genes
AU606574B2 (en) Hepatitis b surface antigen formed by recombinant dna techniques, vaccines diagnostics, cell lines and methods of forming same
NZ213275A (en) Dna probe for the detection of bluetongue virus, and method of detection
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
AU1668788A (en) Method of vaccination for hepatitis b virus
AU596692B2 (en) DNA coding for antigen protein of rinderpest virus
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
ZA868612B (en) Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells
SG139793G (en) Preparation of hepatitis B surface antigen in yeast.
JPS645492A (en) Production of b type hepatitis virus protein in yeast
GR862721B (en) Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired